Johnson & Johnson has informed the EU that it is facing supply problems for its vaccine, which is likely to be officially approved on Thursday. It may not be possible to deliver the targeted 55 million doses by the end of June. This threatens a new setback for the vaccination campaign.
–
On Thursday, Johnson & Johnson expects European approval for its vaccine, which is partly developed by subsidiary Janssen in Beerse. The chance of a green light is very high: the Americans approved …
– .
Related posts:
Roxana Tajvar (35) fled to the Netherlands at the age of 7 and is now director of the Kurhaus | Inl...
Fireman receives high compensation after swimming accident in Hörste | Haller Kreisblatt
Special housing supply measures, restructuring and redevelopment systems likely to be included
Bitcoin touched the sky ... and approached 50 thousand dollars
